diosgenin has been researched along with transforming growth factor beta in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Agha, AM; Ahmed, LA; Obaid, AA; Zaki, HF | 1 |
Han, X; Lin, Y; Liu, K; Peng, J; Qi, Y; Sun, H; Xu, L; Xu, Y; Yin, L; Zhang, X | 1 |
Dinesh Babu, V; Sudhandiran, G; Suresh Kumar, A | 1 |
3 other study(ies) available for diosgenin and transforming growth factor beta
Article | Year |
---|---|
Role of oxidative stress, inflammation, nitric oxide and transforming growth factor-beta in the protective effect of diosgenin in monocrotaline-induced pulmonary hypertension in rats.
Topics: Animals; Caspase 3; Diosgenin; Glutathione; Heart Ventricles; Hypertension, Pulmonary; Inflammation; Lung; Male; Monocrotaline; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxidase; Protective Agents; Pulmonary Artery; Rats, Wistar; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2014 |
Potent effects of dioscin against liver fibrosis.
Topics: Animals; Apoptosis; Cellular Senescence; Diosgenin; Extracellular Matrix; Hepatic Stellate Cells; Hepatocytes; Liver Cirrhosis; Male; Matrix Metalloproteinases; Mitogen-Activated Protein Kinases; Oxidative Stress; Rats; Signal Transduction; Smad Proteins; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta; Wnt Signaling Pathway | 2015 |
Diosgenin inhibits TGF-β1/Smad signaling and regulates epithelial mesenchymal transition in experimental pulmonary fibrosis.
Topics: Animals; Bleomycin; Diosgenin; Epithelial-Mesenchymal Transition; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Wistar; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2022 |